drugset / Trial / NCT02880995

[18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis

NCT02880995

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The first purpose of this study is to determine if dopamine synthesis capacity is significantly lower in treatment non-responders from illness onset relative to treatment responders. And the second purpose of this study is to determine the potential of \[18 fluorine(F)\]-DOPA to be used to predict treatment response to antipsychotic treatment in first episode psychosis.

Timeline

Start
2017-11-01
Primary completion
2019-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Amisulpride Small molecule

Indications